USNA

USANA Health Sciences Inc
NYSECONSUMER DEFENSIVEPACKAGED FOODS

Key Statistics

Market Cap
$390.86M
P/E Ratio
42.34
EPS
$0.50
Beta
0.73
52W High
$38.32
52W Low
$16.60
50-Day MA
$19.15
200-Day MA
$20.21
Dividend Yield
Profit Margin
0.96%
Forward P/E
11.17
PEG Ratio
0.93

About USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company is headquartered in Salt Lake City, Utah.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$925.94M
Gross Profit (TTM)$718.09M
EBITDA$81.56M
Operating Margin5.55%
Return on Equity1.55%
Return on Assets4.13%
Revenue/Share (TTM)$50.40
Book Value$29.45
Price-to-Book0.74
Price-to-Sales (TTM)0.42
EV/Revenue0.274
EV/EBITDA3.16
Quarterly Earnings Growth (YoY)-16.60%
Quarterly Revenue Growth (YoY)0.30%
Shares Outstanding$18.46M
Float$9.87M
% Insiders40.86%
% Institutions56.47%

Historical Volatility

HV 10-Day
47.49%
HV 20-Day
41.40%
HV 30-Day
41.37%
HV 60-Day
45.21%
HV Rank
48.8%

Volatility is currently expanding

Analyst Ratings

Consensus ($39.00 target)

Latest News

Kevin Guest: World Cup Determination Shows the Power of Grit, Preparation, Persistence

SALT LAKE CITY, July 1, 2026 /PRNewswire/ -- As World Cup soccer players push through pressure, fatigue, setbacks and global expectations, Kevin Guest, Chairman and CEO of USANA Health Sciences (NYSE: USNA), says their pursuit of victory carries a lesson that reaches far beyond the field. It comes down to one of the 12 principles from his book, All the Right Reasons: The Piano Principle.

PRNewsWire7/1/2026Neutral
Should Value Investors Buy USANA Health Sciences (USNA) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research6/26/2026Positive
USANA Health Sciences: How The Restructuring Plan Makes It A Strong Buy

USANA Health Sciences is undergoing restructuring, causing temporary margin pressure but positioning for significant future profit expansion. Rise Wellness posted 740% revenue growth, but gross margin fell to 7.1% due to promotional discounts; margin recovery is expected as restocking begins at regular prices. Hiya's revenue dropped 13.3% amid higher CAC from Meta algorithm changes; in-house manufacturing should drive cost savings in H2.

Seeking Alpha6/19/2026Positive
Are Investors Undervaluing USANA Health Sciences (USNA) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research6/10/2026Positive
USANA Earns Dual Best of State Honors for Product Innovation and Development

USANA's CellSentials and Research and Development team honored at the awards SALT LAKE CITY, June 4, 2026 /PRNewswire/ -- USANA, a leader in global nutrition, earned two Best of State awards in Salt Lake City, Utah, recognizing its CellSentials supplements and Research and Development team. USANA took home two Best of State medals this year in the following categories: Dietary Supplement—USANA CellSentials took home this honor for the tenth consecutive year  Research and Development—USANA's R&D team won for the eighth time To learn more about USANA and its award-winning products, please visit USANA.com.

PRNewsWire6/4/2026Neutral

More CONSUMER DEFENSIVE Stocks

Data last updated: 7/9/2026